MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
64 hedge funds and large institutions have $48.1M invested in Marinus Pharmaceuticals, Inc in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
66% less capital invested
Capital invested by funds: $140M → $48.1M (-$92M)
68% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 19
Holders
64
Holding in Top 10
3
Calls
$1.52M
Puts
$579K
Top Buyers
| 1 | +$5.31M | |
| 2 | +$1.94M | |
| 3 | +$1.14M | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$308K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$196K |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$2.71M | |
| 3 | -$1.65M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.5M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$1.12M |